Do we really want to take it all the way Gassy ? Yes we get huge upside but for a small biotech ex Australia to make it all the way are few and far between - yes CSL of course but how many others have failed between where we are now and selling their product on the open market ?
Ideally we partner in some way early next year, this is when i see the re-rate happening. One thing is clear, our leverage in any future partnership has increased significantly with the cash in the bank
$15m cap raise Fresh Equities at 24c, page-628
-
- There are more pages in this discussion • 228 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
